At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on patient advocacy groups in hematology, efforts to reduce racial disparities in multiple myeloma clinical trials, real-world outcomes of novel agents in the community setting, and much more!

Exploring Results of the IsKia Trial in Newly Diagnosed Multiple Myeloma: Annemiek Broijl, MD

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Exploring Results of the IsKia Trial in Newly Diagnosed Multiple Myeloma: Annemiek Broijl, MD

Oncology Data Advisor®